DNAJC13 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.910000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.639600E-01
Normal-vs-Stage2
4.369600E-01
Normal-vs-Stage3
3.184100E-02
Normal-vs-Stage4
6.849000E-01
Stage1-vs-Stage2
7.046200E-01
Stage1-vs-Stage3
1.204830E-01
Stage1-vs-Stage4
1.717450E-01
Stage2-vs-Stage3
9.070200E-02
Stage2-vs-Stage4
1.005400E-01
Stage3-vs-Stage4
6.338500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.457200E-01
Normal-vs-AfricanAmerican
7.564000E-01
Normal-vs-Asian
3.385400E-01
Caucasian-vs-AfricanAmerican
4.232000E-01
Caucasian-vs-Asian
7.772000E-01
AfricanAmerican-vs-Asian
4.295600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.208600E-01
Normal-vs-Female
3.649600E-01
Male-vs-Female
9.545200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.318030E-01
Normal-vs-Age(41-60Yrs)
6.987800E-01
Normal-vs-Age(61-80Yrs)
2.845400E-01
Normal-vs-Age(81-100Yrs)
3.998600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.365200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.013600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.236600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.741960E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.658400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.161200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.251830E-01
Normal-vs-Daily Drinker
1.275190E-01
Normal-vs-Weekly Drinker
4.782200E-01
Normal-vs-Occasional Drinker
8.038600E-01
Normal-vs-Social Drinker
6.459400E-01
Non Drinker-vs-Daily Drinker
6.886600E-01
Non Drinker-vs-Weekly Drinker
2.508000E-01
Non Drinker-vs-Occasional Drinker
1.209790E-01
Non Drinker-vs-Social Drinker
1.225840E-01
Daily Drinker-vs-Weekly Drinker
1.914400E-01
Daily Drinker-vs-Occasional Drinker
7.182400E-02
Daily Drinker-vs-Social Drinker
1.010210E-01
Weekly Drinker-vs-Occasional Drinker
5.865000E-01
Weekly Drinker-vs-Social Drinker
7.422000E-01
Occasional Drinker-vs-Social Drinker
8.058400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.111200E-01
Normal-vs-Grade 2
7.396200E-02
Normal-vs-Grade 3
7.315900E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.849500E-04
Grade 1-vs-Grade 3
2.593500E-04
Grade 1-vs-Grade 4
5.111200E-01
Grade 2-vs-Grade 3
9.627700E-02
Grade 2-vs-Grade 4
7.396200E-02
Grade 3-vs-Grade 4
7.315900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.967000E-01
Normal-vs-NonDiabetic
2.845400E-01
Diabetic-vs-NonDiabetic
8.611000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.768200E-01
Normal-vs-NoPancreatitis
3.001600E-01
Pancreatitis-vs-NoPancreatitis
5.833800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.563800E-01
Normal-vs-N1
4.246000E-01
N0-vs-N1
3.230000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.765800E-01
Normal-vs-TP53-NonMutant
3.695400E-01
TP53-Mutant-vs-TP53-NonMutant
1.498090E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
